BSD Medical is Now Pyrexar Medical

The complete line of BSD Hyperthermia products are availble thru Pyrexar Medical

In the fourth installment of the 4-part ABC story, we hear from doctors around the world who use hyperthermia as a standard cancer treatment. We ask them why they think the US medical community is behind in this life saving technology.  If you missed part three, you can view it here.

The ABC news team included reporter Nadia Crow, videographer/editor John Eulberg and VP/GM of Nexstar Broadcasting Group, Richard Doutrè Jones.  This video is their third installment "Hyperthermia used Outside the US". Follow the story link for a complete transcript.  Video included in this post, courtesy of Good4Utah.com

Part 1Part 2Part 3 • Part 4 • Part 5

pyrexar award 2016Dr. Gerhard Sennewald, Paul TurnerThe International Congress of Hyperthermic Oncology (ICHO) is a quadrennial event bringing together the annual gatherings of the Society of Thermal Medicine (STM), European Society of Hyperthermic Oncology (ESHO) and the Asian Society of Hyperthermic Oncology (ASHO) to a common venue.  Clinicians and Researchers from around the world gather to share their findings on the effect of hyperthermia (heat) as a weapon in the fight against cancer.

At this event, Pyrexar was honored to present their Lifetime Achievement Award to individuals whose contributions to the field have directly affected the survival of those with life threatening cancer. 

The first recipient of the Pyrexar LTA award is Paul Turner, considered the father of phased array radio frequency hyperthermia.  Holder of multiple patents in the arena of thermal therapy, Paul has been working in the field for almost 40 years and his contributions to cancer therapies are realized in the entire Pyrexar Medical product line.

The second recipient, Gerhard Sennewald, PhD, is the president of Sennewald Medizintechnik GmbH in Munich, Germany.  A long time board member of the former BSD Medical and current Pyrexar Medical.  His relationships with the European cancer treatment community and his team of engineers, are instrumental in the development of Image Guided Thermal Therapy. IGTT uses Magnetic Resonance Imaging to determine tumor core temperature to guide the application of hyperthermia in the treatment of cancer.

"We are so fortunate to have these gentlemen associated with Pyrexar" says Mark Falkowksi, CEO. "Their integrity, focus and passion has given the world a technology that is for the greater good.” We look forward to future contributions toward the development of new, innovative and exciting technologies in the fight against cancer.

Group Photo cropped

From The Desk of Mark Falkowski, CEO Pyrexar Medical

As Pyrexar Medical celebrates it first anniversary, I reflect on the amazing achievements of the past year.  Our products are being represented in over 50 countries in the world, with many more in line for distribution. Hyperthermia is on the precipice of a cancer fighting revolution.

I want to acknowledge those who have pioneered ahead of us, testing, focusing and perfecting the treatment systems into what we have today.  To those in research for discovering the biology of the immune system that reveals why heating cancer tumors is so successful. To the patient advocates that challenge our medical system in the U.S. by demanding hyperthermia. And to the doctors, all over the world, that reach out for new, better and more effective ways to treat cancer.

And most importantly, I want to thank the Pyrexar Team for sharing this same vision. I recall a Confucius quote “Choose a job you love, and you will never have to work a day in your life.” We all realize that every system that ships out of this facility is changing the life of a patient and a family.  I am proud to know we have built a company where we can make a difference.

The world is beginning to embracing the technology of heat and we will continue to prove... Thermal Therapy Works.  Immunology is our next frontier.

 

Pyrexar Day is April 11th, 2016 at this year's ICHO in New Orleans.  We have some last minute updates to our speaker schedule.  We will be hosting a "working lunch" starting at 12:15p.  Looking forward to seeing you at the event.

pyrexar day

Pyrexar Day Event Calendar - April 11, 2016
8:30a - 9:00a Meet and Greet - Refreshments
9:00a - 9:15a Welcome to Pyrexar Day - Mark Falkowski, CEO
9:15a - 10:00a Hyperthermia: A maturing technology moving toward more focused heating - Gerard Van Rhoon, PhD., Erasmus Hospital, Netherlands
10:00a - 10:45a Exploration of BSD-2000 System Applied to Clinical Treatment of Tumors – Dr. Sun Jinghua, Associate Professor, 2nd Affiliated Hospital of Dalian Medical University
10:45a - 11:30p Comprehensive Thermal Oncology Program at the University of Maryland: External, Interstitial and Proton Thermal Therapy - Dr. Zeljko Vujaskovic, University of Maryland Medical Center
11:30p - 12:15p New Product Announcement & Presentation – Jason Ellsworth, VP Pyrexar Medical
12:30p – 1:15p Capacitive vs Phased Array Hyperthermia - Paul Turner, CTO Pyrexar Medical
1:15p – 2:00p

Hyperthermia and Pancreatic Cancer; Adjunct to Radiation, Chemotherapy or Both - Dr. Curt Heese, Cancer Treatment Centers of America, Philadelphia

2:00p – 2:45p

Using Chemotherapy plus Hyperthermia for Advanced Liver Cancer - Xiao Shaowen, Associate Chief Physician. Beijing University

2:45p – 3:30p Quality Assurance of MR-Guided Deep Regional Hyperthermia in Children with Cancer – Dr. Ruediger Wessalowski Heinrich-Heine University Duesseldorf, Germany
3:30p – 4:15p Hyperthermia Adjunct to Chemotherapy Sarcoma Study - Dr. Rolf Issels, Ludwig-Maximilians-University of Munich
4:15p - 5:00p Hyperthermia with Proton Therapy: The thermoradiobiological basis and the early results from HYPROSAR study – Dr. Niloy Datta, Ksantonsspital Aarau
5:00p - 5:45p  Concepts For Future Deep Phased Array Systems - Paul Turner, CTO Pyrexar Medical
 6:00p  Pyrexar Award Presentation

This event is open to all Conference Attendees at no additional charge.  The event schedule above may change. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

EVENT LOCATION: Intercontinental Hotel New Orleans, 444 St Charles Ave, New Orleans, LA 70130, USA